Philip Toleikis
Chief Tech/Sci/R&D Officer at SERNOVA CORP.
Net worth: 2 M $ as of 30/03/2024
Profile
Philip M.
Toleikis is currently the Director & Chief Technology Officer at Sernova Corp.
since 2023.
He is also a Member of the Medway Working Group.
Previously, he worked as the VP-Pharmacology, Research & Development at Angiotech Pharmaceuticals, Inc. from 1999 to 2006.
Dr. Toleikis holds a doctorate degree from the University of British Columbia, a graduate degree from the University of Michigan, and an undergraduate degree from the University of Vermont.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SERNOVA CORP.
1.74% | 24/04/2023 | 5,273,598 ( 1.74% ) | 2 M $ | 30/03/2024 |
Philip Toleikis active positions
| Companies | Position | Start |
|---|---|---|
| SERNOVA CORP. | Chief Tech/Sci/R&D Officer | 04/09/2023 |
| Medway Working Group | Corporate Officer/Principal | - |
Former positions of Philip Toleikis
| Companies | Position | End |
|---|---|---|
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 31/12/2005 |
Training of Philip Toleikis
| University of British Columbia | Doctorate Degree |
| University of Michigan | Graduate Degree |
| University of Vermont | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SERNOVA CORP. | Health Technology |
| Private companies | 2 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
| Medway Working Group |
- Stock Market
- Insiders
- Philip Toleikis
